Balance Sheet
Accumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GCM Grosvenor (GCMG) Liabilities and Shareholders Equity (2019 - 2026)

GCM Grosvenor has reported Liabilities and Shareholders Equity over the past 7 years, most recently at $813.8 million for Q4 2025.

  • For Q4 2025, Liabilities and Shareholders Equity rose 32.81% year-over-year to $813.8 million; the TTM value through Dec 2025 reached $2.7 billion, up 21.87%, while the annual FY2025 figure was $813.8 million, 32.81% up from the prior year.
  • Liabilities and Shareholders Equity for Q4 2025 was $813.8 million at GCM Grosvenor, up from $685.9 million in the prior quarter.
  • Over five years, Liabilities and Shareholders Equity peaked at $813.8 million in Q4 2025 and troughed at $450.8 million in Q2 2023.
  • A 5-year average of $561.7 million and a median of $539.4 million in 2021 define the central range for Liabilities and Shareholders Equity.
  • Biggest five-year swings in Liabilities and Shareholders Equity: decreased 23.62% in 2022 and later surged 32.81% in 2025.
  • Year by year, Liabilities and Shareholders Equity stood at $581.6 million in 2021, then dropped by 15.94% to $488.9 million in 2022, then increased by 3.27% to $504.9 million in 2023, then increased by 21.35% to $612.7 million in 2024, then soared by 32.81% to $813.8 million in 2025.
  • Business Quant data shows Liabilities and Shareholders Equity for GCMG at $813.8 million in Q4 2025, $685.9 million in Q3 2025, and $636.9 million in Q2 2025.